Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	83.65	-0.62	-3.80
Graham Fair Price	12.61	2.52	2.24
PEG	91.10	-0.04	0.02
Price/Book	-36.49	0.18	0.28
Price/Cash Flow	-11.37	-3.87	-3.47
Prices/Earnings	53.97	-1.30	-2.82
Price/Sales	17.43	10.58	9.01
Price/FCF	-11.37	-3.87	-3.47
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	282.62	-0.32	0.08
Operating Margin	-112.85	-2.64	-1.24
ROA	-37.21	-0.03	-0.02
ROE	-0.02	-0.03	-37.97
ROIC	-0.03	-0.04	-29.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.35	0.20	76.06
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.33	-0.11	66.27
EPS QOQ	-1.34	-0.32	75.91
FCF QOQ	-0.18	0.45	144.81
Revenue QOQ	0.83	-0.48	-42.43
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.85	9.15	33.53
Days Sales Outstanding (DSO)	134.88	274.67	103.64
Inventory Turnover	13.13	9.83	-25.11
Debt/Capitalization	0.01	0.02	67.75
Quick Ratio	13.83	11.94	-13.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.00	2.88	-4.13
Cash	1.12	1.03	-8.06
Capex	-0.14	-0.01	90.37
Free Cash Flow	-0.24	-0.13	45.33
Revenue	0.09	0.05	-48.15
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	14.55	12.61	-13.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.80	4.03	-16.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating